ArticleEBioMedicine2025

Discovery and validation of biomarkers for Parkinson's disease from human cerebrospinal fluid using mass spectrometry-based proteomics analysis.

Sungtaek Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.